Dublin, Feb. 17, 2025 (GLOBE NEWSWIRE) — The “Point of Care Diagnostics Market Size and Share Analysis – Growth Trends and Forecast Report 2025-2033” report has been added to ResearchAndMarkets.com’s offering.
The point-of-care diagnostics market is expected to increase from US$ 50.08 billion in 2024 to US$ 105.22 billion in 2033, indicating a compound annual growth rate of 8.60% from 2025 to 2033. This growth can be attributed to the progression in diagnostic technologies, demand for faster and more efficient testing, and awareness of benefits arising from accessible healthcare solutions in remote or underserved locations.
The development of point-of-care diagnostics is promoted by advanced diagnostic technologies such as miniaturization, sensor integration, and artificial intelligence. Modern devices become more precise, portable, and user-friendly, thereby enabling health care providers to make quicker and more efficient testing decisions. Improved connectivity like Bluetooth and cloud-based systems ensure the real-time transfer of data, further increasing the speed of decision-making. This will allow point-of-care diagnostics to reach a wider cross-section of medical settings, opening avenues for expansion in the market.
Rising Prevalence of Chronic Diseases
Increasing prevalence of chronic diseases such as diabetes, cardiovascular diseases, and respiratory disorders is one major growth driver for the point-of-care diagnostics market. Continuous monitoring and early detection are essential for managing the said conditions effectively. The point-of-care devices allow patients and healthcare professionals to measure vital parameters such as blood glucose, cholesterol levels, and heart functions at home or on-site, reducing the need for frequent hospital visits. The convenience this offers is a key driver of demand for POC diagnostic solutions and supports growth in the market.
Increasing Demand for Rapid and Accessible Healthcare
The growing demand for rapid, easy, and cost-effective health care solutions is one of the factors that drive the growth of the point-of-care diagnostics market. Patients in remote or underserved areas are seeking immediate results, and POC diagnostics allow for quick testing and the making of timely treatment decisions. Moreover, the COVID-19 pandemic has demonstrated the need for accessible and rapid testing. As healthcare systems work to deliver effective care, there is growing demand for POC diagnostic tools that further enhance the industry’s growth trend.
Obstacles in the Point of Care Diagnostics Market
Regulatory and Compliance Challenges
Regulatory issues pose some of the biggest problems to the point of care diagnostics market. Approvals for diagnostic devices have region-specific differences, with strict requirements for accuracy, safety, and performance. In many cases, manufacturers must navigate complex regulations from organizations like the FDA and CE Mark, which can delay product launches and increase costs. Compliance with these regulations is crucial to ensure patient safety and maintain trust in diagnostic results, making it challenging for market players to introduce innovative products quickly.
Accuracy and Reliability Concerns
Despite technological advancements, concerns over the accuracy and reliability of point-of-care diagnostic devices remain challenging. The main advantage of POC testing is convenience and speed. However, many devices might have lower sensitivity and specificity compared to lab tests, which can sometimes result in false positives or negatives that could influence clinical decision-making. Ensuring the accuracy of tests and consistency in quality across different settings is key to the broad adoption and trust in point-of-care diagnostics, an area where constant innovation in device technology and validation will be needed.
Infectious Diseases Kits Market
The Infectious Diseases Kits Market in the point-of-care diagnostics sector is growing rapidly, motivated by the demand for quicker, more accurate, and accessible disease detection. Point-of-care kits for infectious diseases provide immediate results for patients in hospitals, clinics, and even at home. These kits are critical to the management of COVID-19, influenza, and malaria outbreaks. Technological advancements in molecular diagnostics and antigen/antibody testing are enhancing the accuracy and speed of these tests, supporting market growth in global healthcare settings.
Agglutination Point-of-care Diagnostics Market
The Agglutination Point-of-Care (POC) Diagnostics Market is growing due to the demand for quick, reliable, and cost-effective diagnostic solutions. Agglutination-based tests use clumping of particles due to exposure to specific antibodies or antigens. This type of test is generally applied in the diagnosis of infectious diseases, blood typing, and some medical conditions. Agglutination tests give immediate results and, thus are used more commonly for emergencies and distant settings. Portable devices have emerged, along with health access in more recent times, driving growth within this market. However, challenges like sensitivity issues and regulatory hurdles may impact the adoption of agglutination POC diagnostics.
Prescription-Based Devices POC diagnostics market
The Prescription-Based Devices Point-of-Care (POC) Diagnostics Market is expanding due to the growing demand for personalized and accurate healthcare solutions. These devices require a prescription and are designed for monitoring and diagnosing specific conditions like diabetes, cardiovascular diseases, and respiratory infections. Prescription-based POC diagnostics provide the benefit of delivering comprehensive, precise results that assist in the proper management of chronic diseases. With advancements in medical devices and the growing accessibility of healthcare, the market is expanding. However, regulatory barriers and the requirement for appropriate healthcare provider involvement in prescribing these devices create obstacles.
Home Care POC diagnostics market
The Home Care Point-of-Care (POC) Diagnostics Market is experiencing a fast-growing trend since patients are more and more looking for the most convenient and cost-effective ways to monitor their health at home. Home care POC diagnostics include devices monitoring conditions like diabetes, hypertension, and cholesterol, letting people test and track their health without frequent visits to healthcare facilities.
Advancements in user-friendly, accurate diagnostic devices and growing awareness about preventive healthcare are contributing to market expansion. Additionally, the COVID-19 pandemic accelerated demand for home-based testing. Challenges include ensuring accurate results, regulatory approval, and overcoming concerns about data privacy and device reliability.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 240 |
| Forecast Period | 2024 – 2033 |
| Estimated Market Value (USD) in 2024 | $50.08 Billion |
| Forecasted Market Value (USD) by 2033 | $105.22 Billion |
| Compound Annual Growth Rate | 8.6% |
| Regions Covered | Global |
Company Analysis: Overview, Recent Developments, Revenue Analysis
- Sysmex
- Abbott Laboratories (US)
- Becton Dickinson and Company (US)
- Danaher Corporation (US)
- Quidel Diagnostics (US)
- F. Hoffmann-La Roche Ltd
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories Inc.
Key Topics Covered:
1. Introduction
2. Research Methodology
3. Executive Summary
4. Market Dynamic
4.1 Growth Drivers
4.2 Challenges
5. Global Point of Care Diagnostics Market
6. Market Share
6.1 By Product
6.2 By Technology
6.3 By Mode of Prescription
6.4 By End Users
6.5 By Country
7. Product
7.1 Glucose Monitoring Kits
7.2 Infectious Diseases Kits
7.3 Pregnancy & Fertility Testing Kits
7.4 Haematology Testing Kits
7.5 Cardiometabolic Monitoring Kits
7.6 Urinalysis Testing Kits
7.7 Cholesterol Test Strips
7.8 Drugs Abuses Testing Kits
7.9 Others
8. Technology
8.1 Lateral Flow
8.2 Agglutination
8.3 Flow Through
8.4 Solid phase
8.5 Biosensor
8.6 Others
9. Mode of Prescription
9.1 Prescription-Based Devices
9.2 Over-the-counter (OTC)-Based Devices
10. End Users
10.1 Professional Diagnostic Centers
10.2 Research Laboratories
10.3 Home Care
10.4 Others
11. Country
11.1 North America
11.1.1 United States
11.1.2 Canada
11.2 Europe
11.2.1 France
11.2.2 Germany
11.2.3 Italy
11.2.4 Spain
11.2.5 United Kingdom
11.2.6 Belgium
11.2.7 Netherlands
11.2.8 Turkey
11.3 Asia Pacific
11.3.1 China
11.3.2 Japan
11.3.3 India
11.3.4 South Korea
11.3.5 Thailand
11.3.6 Malaysia
11.3.7 Indonesia
11.3.8 Australia
11.3.9 New Zealand
11.4 Latin America
11.4.1 Brazil
11.4.2 Mexico
11.4.3 Argentina
11.5 Middle East & Africa
11.5.1 Saudi Arabia
11.5.2 UAE
11.5.3 South Africa
12. Porter’s Five Analysis
13. SWOT Analysis
14. Key Players Analysis
For more information about this report visit https://www.researchandmarkets.com/r/86t01m
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Point of Care Diagnostics Market
